Year |
Citation |
Score |
2019 |
Revankar CM, Bologa CG, Pepermans RA, Sharma G, Petrie WK, Alcon SN, Field AS, Ramesh C, Parker MA, Savchuk NP, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling. Cell Chemical Biology. PMID 31706983 DOI: 10.1016/J.Chembiol.2019.10.009 |
0.615 |
|
2013 |
Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, Hathaway HJ, Prossnitz ER. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstetrics and Gynecology International. 2013: 472720. PMID 24379833 DOI: 10.1155/2013/472720 |
0.629 |
|
2012 |
Berryhill GE, Gloviczki JM, Trott JF, Aimo L, Kraft J, Cardiff RD, Paul CT, Petrie WK, Lock AL, Hovey RC. Diet-induced metabolic change induces estrogen-independent allometric mammary growth. Proceedings of the National Academy of Sciences of the United States of America. 109: 16294-9. PMID 22988119 DOI: 10.1073/Pnas.1210527109 |
0.316 |
|
2012 |
Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF, Hudson LG. Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. Dermatology Research and Practice. 2012: 309587. PMID 22312325 DOI: 10.1155/2012/309587 |
0.315 |
|
2011 |
Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. The Journal of Steroid Biochemistry and Molecular Biology. 127: 358-66. PMID 21782022 DOI: 10.1016/J.Jsbmb.2011.07.002 |
0.615 |
|
2011 |
Petrie WK, Hovey RC. A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file. Breast Cancer Research : Bcr. 13: 301. PMID 21345282 DOI: 10.1186/Bcr2802 |
0.364 |
|
2009 |
Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, et al. In vivo effects of a GPR30 antagonist. Nature Chemical Biology. 5: 421-7. PMID 19430488 DOI: 10.1038/Nchembio.168 |
0.654 |
|
Show low-probability matches. |